Litcius/Paper detail

NIR‐II Organic Nanotheranostics for Precision Oncotherapy

Hanming Dai, Xiaorui Wang, Jinjun Shao, Wenjun Wang, Xiaozhou Mou, Xiaochen Dong

2021Small105 citationsDOI

Abstract

Precision oncotherapy can remove tumors without causing any apparent iatrogenic damage or irreversible side effects to normal tissues. Second near-infrared (NIR-II) nanotheranostics can simultaneously perform diagnostic and therapeutic modalities in a single nanoplatform, which exhibits prominent perspectives in tumor precision treatment. Among all NIR-II nanotheranostics, NIR-II organic nanotheranostics have shown an exceptional promise for translation in clinical tumor treatment than NIR-II inorganic nanotheranostics in virtue of their good biocompatibility, excellent reproducibility, desirable excretion, and high biosafety. In this review, recent progress of NIR-II organic nanotheranostics with the integration of tumor diagnosis and therapy is systematically summarized, focusing on the theranostic modes and performances. Furthermore, the current status quo, problems, and challenges are discussed, aiming to provide a certain guiding significance for the future development of NIR-II organic nanotheranostics for precision oncotherapy.

Topics & Concepts

NanotechnologyBiocompatibilityMedicineMaterials scienceBiomedical engineeringMetallurgyNanoplatforms for cancer theranosticsAdvanced Nanomaterials in CatalysisCancer Research and Treatments
NIR‐II Organic Nanotheranostics for Precision Oncotherapy | Litcius